Xiaochun Hu1, Weida Wang1, Ye Wang1, Ke Liu2. 1. Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. 2. School of Nursing, Sun Yat-sen University, Guangzhou, Guangdong, China.
Abstract
OBJECTIVE: Fear of cancer recurrence (FCR) is a common psychosocial sequela among cancer survivors, but data on patients with multiple myeloma are scarce. This study calculated the prevalence of FCR and identified family and social factors that predict FCR in the study population. METHODS: We recruited 127 myeloma patients and their partners to participate in a cross-sectional survey from a regional tertiary cancer centre in China. The questionnaires included items on demographic characteristics and from the fear of disease progression simplified scale, family hardiness index and Social Support Scale. Univariate and multivariate regression was used to identify predictors of FCR. RESULTS: Of the participants, 56.4% patients reported high-level FCR, which was similar to the partner-reported proportion. The partners' FCR was positively associated with the patients' FCR, while family hardiness and social support were statistically significant, negative predictors. CONCLUSIONS: Interventions to mitigate partners' FCR and improve family hardiness and social support may help with the psychological adjustment and well-being of myeloma patients.
OBJECTIVE: Fear of cancer recurrence (FCR) is a common psychosocial sequela among cancer survivors, but data on patients with multiple myeloma are scarce. This study calculated the prevalence of FCR and identified family and social factors that predict FCR in the study population. METHODS: We recruited 127 myelomapatients and their partners to participate in a cross-sectional survey from a regional tertiary cancer centre in China. The questionnaires included items on demographic characteristics and from the fear of disease progression simplified scale, family hardiness index and Social Support Scale. Univariate and multivariate regression was used to identify predictors of FCR. RESULTS: Of the participants, 56.4% patients reported high-level FCR, which was similar to the partner-reported proportion. The partners' FCR was positively associated with the patients' FCR, while family hardiness and social support were statistically significant, negative predictors. CONCLUSIONS: Interventions to mitigate partners' FCR and improve family hardiness and social support may help with the psychological adjustment and well-being of myelomapatients.
Authors: Lauren E Latella; Madeline Rogers; Howard Leventhal; Patricia A Parker; Steven Horwitz; Matthew J Matasar; Carma L Bylund; David W Kissane; Kara Franco; Smita C Banerjee Journal: J Psychosoc Oncol Date: 2019-10-16
Authors: S Vincent Rajkumar; Meletios A Dimopoulos; Antonio Palumbo; Joan Blade; Giampaolo Merlini; María-Victoria Mateos; Shaji Kumar; Jens Hillengass; Efstathios Kastritis; Paul Richardson; Ola Landgren; Bruno Paiva; Angela Dispenzieri; Brendan Weiss; Xavier LeLeu; Sonja Zweegman; Sagar Lonial; Laura Rosinol; Elena Zamagni; Sundar Jagannath; Orhan Sezer; Sigurdur Y Kristinsson; Jo Caers; Saad Z Usmani; Juan José Lahuerta; Hans Erik Johnsen; Meral Beksac; Michele Cavo; Hartmut Goldschmidt; Evangelos Terpos; Robert A Kyle; Kenneth C Anderson; Brian G M Durie; Jesus F San Miguel Journal: Lancet Oncol Date: 2014-10-26 Impact factor: 41.316
Authors: Peter Herschbach; Petra Berg; Andrea Dankert; Gabriele Duran; Ursula Engst-Hastreiter; Sabine Waadt; Monika Keller; Robert Ukat; Gerhard Henrich Journal: J Psychosom Res Date: 2005-06 Impact factor: 3.006